Clene (CLNN) Receivables - Other (2025 - 2026)
Clene (CLNN) posted Receivables - Other of $598000.0 for Q2 2026, down 22.74% on a QoQ basis from $774000.0 in Q2 2025, and down 22.74% year-over-year from $774000.0 in Q2 2025.
Powered by 
Analysis
Clene (CLNN) Receivables - Other (2025 - 2026) Analysis & Trends
Clene has reported Receivables - Other for 2 years, with the latest figure at $598000.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 598,000.00 |
| Jun 30, 2025 | 774,000.00 |
| Mar 31, 2025 | 989,000.00 |